A Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Generalized Refractory Myasthenia Gravis (GMG)

Administered By

Neurology, Neuromuscular Disease

Awarded By

Alexion Pharmaceuticals, Inc.

Contributors

Juel, Vern Charles Principal Investigator

Start/End

January 15, 2014 - June 30, 2017